Neurosense Therapeutics Ltd (NRSN) — Defensive Interval Ratio
Neurosense Therapeutics Ltd (NRSN) has a Defensive Interval Ratio of 5 days as of December 2025. Defensive assets of $33.00K (cash $-, short-term investments $-, receivables $33.00K) cover 5 days of daily cash needs of $6.89K/day. See NRSN working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Neurosense Therapeutics Ltd Defensive Interval Ratio (2019–2025)
This chart shows how Neurosense Therapeutics Ltd's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the ratio stands at 5 days, meaning defensive assets of $33.00K can fund 5 days of operations without new revenue. See Neurosense Therapeutics Ltd (NRSN) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Neurosense Therapeutics Ltd (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for Neurosense Therapeutics Ltd from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Neurosense Therapeutics Ltd (NRSN) total market value.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 5 days | $33.00K | $6.89K/day | $- | $- | ▼ -25 days |
| 2024 | 30 days | $164.00K | $5.46K/day | $- | $- | ▲ +13 days |
| 2023 | 18 days | $166.00K | $9.48K/day | $- | $0.00 | ▼ -760 days |
| 2022 | 778 days | $3.68 Million | $4.73K/day | $- | $3.55 Million | ▲ +669 days |
| 2021 | 109 days | $178.00K | $1.64K/day | $- | $0.00 | ▲ +18 days |
| 2020 | 91 days | $30.00K | $328.77/day | $- | $- | ▼ -86 days |
| 2019 | 178 days | $18.00K | $101.37/day | $- | $- | — |